Scherzinger et al., “Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo”, Cell, 90:549-558 (Aug. 8, 1997). |
Ciechanover et al., Commentary “The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death”, Proc. Natl. Acad. Sci. USA, 95:2727-2730 (Mar. 1998). |
Cooper et al., “Rapid Communication Polyglutamine domains are substrates of tissue transglutaminase: Does Transglutaminase play a role in expanded CAG/Poly-Q neurodegenarative diseases!”, Journal of Neurochemistry, 69(1):431-434 (1997). |
Jeon et al., “QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing 112”, Nature Genetics, 21:158-160 (Feb. 1999). |
Skinner et al., “Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures”, Nature, 389:971-974 (Oct. 30, 1997). |
Matilla et al., “The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1”, Nature, 389:974-978 (Oct. 30, 1997). |
Burke et al., “Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH”, Nature Medicine, 2(3)347-350 (Mar. 1996). |
Cariello et al., “Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease”, Hum. Genet., 98:6330635 (1996). |
Dieterich et al., “Identification of tissue transglutaminase as the anutoantigen of celiac disease”, Nature Medicine, 3(7)797-801 (Jul. 1997). |
Ciechanover, “The ubiquitin-proteasome proteolytic pathway”, Cell, 79:13-21 (Oct. 7, 1994). |
Steinmann, “Escape from “Horror Autotoxicus”: Pathogenesis and treatment of autoimmune disease”, Cell, 80:7-10 (Jan. 13, 1995). |
Green, “Letter to the Editor Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism” Cell, 74:955-956 (Sep. 24, 1993). |
Kahlem et al., “Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system”, Proc. Natl. Acad. Sci, USA, 93:14580-14585 (Dec. 1996). |
Kahlem et al., “Transglutaminase action imitates Huntington's disease: Selective polymerization of Huntingtin containing expanded polyglutamine”, Molecular Cell, 1:595-601 (Mar. 1998). |
Abstract—Ferguson, “Use of transglutaminase modulators to promote healing of wounds and fibrotic disorders”, HCAPLUS, (1999). |
Abstract—Chandradhekar et al., “Parasitic nematode transglutaminase proteins and nucleic acid molecules, and their uses for inhibitor screening and recombinant vaccines”, HCAPLUS (1999). |